Please try another search
GlaxoSmithKline Pakistan Limited operates as a biopharma company in Pakistan and internationally. It deals in anti-infective, dermatology, respiratory, analgesics, immunology, oncology, urology, HIV, vaccines, and analgesics therapy areas. The company sells its products under the Augmentin, Velosef, Amoxil, Dermovate, Clobevate, Betnovate, Cutivate, Calpol, Boostrix, Rotarix, Havrix, and Synflorix. The company was founded in 2001 and is headquartered in Karachi, Pakistan. GlaxoSmithKline Pakistan Limited is a subsidiary of GSK plc.
Name | Age | Since | Title |
---|---|---|---|
Maheen Rahman | - | 2018 | Independent Director |
Mehmood Mandviwalla | - | 2011 | Non-Executive Director |
Simon Foster | - | 2022 | Non-Executive Director |
Erum Shakir Rahim | - | 2020 | CEO & Executive Director |
Hasham Ali Baber | - | 2021 | CFO & Executive Director |
Lai Kuen Goh | - | 2022 | Non Executive Chairman |
Muneer Kamal | - | 2020 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review